Therefore, the purpose of this article is to introduce the mechanism of immune dysregulation in sepsis, demonstrate the regulatory effects of PD-1 signaling pathway on various kinds of sepsis-related immune cells, and explore the application prospect of blocking PD-1 signaling pathway in immunomodulatory therapy of sepsis and problems to be solved in future research. This evidence concerns the gene PDCD1 and Sepsis.